Oculis Holding AG — Investor Relations & Filings
Oculis Holding AG is a global, clinical-stage biopharmaceutical company focused on developing innovative therapies for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs. The company's pipeline aims to transform current treatment paradigms. Key candidates include OCS-01, a topical eye drop using the proprietary OPTIREACH® technology, investigated as a potential first non-invasive treatment for Diabetic Macular Edema (DME). Another lead asset is Privosegtor, a novel peptoid small molecule being developed as a neuroprotective therapy for optic neuropathies such as Acute Optic Neuritis. The pipeline also features Licaminlimab, an anti-TNFα eye drop candidate for treating Dry Eye Disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2023-07-06 | English | |
| 424B3 | 2023-06-13 | English | |
| 6-K | 2023-06-13 | English | |
| 424B3 | 2023-06-07 | English | |
| 424B4 | 2023-06-02 | English | |
| 6-K | 2023-06-01 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13626593 | 6-K | 2023-07-06 | English | ||
| 13626595 | 424B3 | 2023-06-13 | English | ||
| 13626596 | 6-K | 2023-06-13 | English | ||
| 13626597 | 424B3 | 2023-06-07 | English | ||
| 13626598 | 424B4 | 2023-06-02 | English | ||
| 13626599 | 6-K | 2023-06-01 | English | ||
| 13626600 | Regulatory Filings 2023 | 2023-06-01 | English | ||
| 13626601 | 6-K | 2023-05-30 | English | ||
| 13626602 | Regulatory Filings 2023 | 2023-05-30 | English | ||
| 13626603 | Regulatory Filings 2023 | 2023-05-30 | English | ||
| 13626604 | F-1 | 2023-05-30 | English | ||
| 13626605 | 424B3 | 2023-05-24 | English | ||
| 13626606 | 6-K | 2023-05-23 | English | ||
| 13626608 | Regulatory Filings 2023 | 2023-05-17 | English | ||
| 13626607 | S-8 | 2023-05-15 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Oculis Holding AG, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Oculis Holding AG via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/8640/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=8640 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=8640 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=8640 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 8640}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Oculis Holding AG (id: 8640)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.